Literature DB >> 28622317

Assessment of patient-reported outcome and quality of life improvement following surgery for epiphora.

Z Sipkova1,2, O Vonica1,2, O Olurin2, E E Obi1,2, A R Pearson1,2.   

Abstract

PurposeTo assess and compare the subjective improvement in symptoms and quality of life in adult patients who underwent commonly performed oculoplastic surgical interventions to treat epiphora.Materials and methodsA prospective study was undertaken involving all adult patients undergoing dacryocystorhinostomy (DCR), lid tightening (lateral tarsal strip or lateral wedge resection), and punctoplasty surgery at our institution. We assessed severity of epiphora preoperatively using the Munk score. At 3 months postoperatively, all patients were sent postal questionnaires comprising of Munk score, 'social impact score' from validated Lac-Q questionnaire ranging from 0 (no impact) to 5 (maximal negative impact) and Glasgow Benefit Inventory (GBI) score, ranging from -100 (maximal detriment) to +100 (maximal benefit).ResultsA total of 134 questionnaires were sent with an overall response rate of 74.6%. For the purpose of data analysis, patients were divided into four groups: DCR, lid tightening, punctoplasty, and combined group (lid tightening plus punctoplasty). There was statistically significant improvement in subjective epiphora postoperatively, as assessed by Munk score (P<0.001) in all groups. The total GBI scores were +42.67 (95% CI: 33.42-51.91) for DCR, +19.65 (95% CI: 10.33-28.97) for lid tightening, +16.06 (95% CI: 2.65-29.48) for punctoplasty, and +26.53 (95% CI: 13.15-39.90) for the combined group, demonstrating a positive change in health status for all groups. There was negative correlation between total GBI and post-operative Munk scores (r=-0.58, P<0.001), and positive correlation between Lac-Q and Munk scores (r=0.65, P<0.001).ConclusionPatients derived significant improvement in symptoms and health-related quality of life benefit following all surgical interventions for epiphora.

Entities:  

Mesh:

Year:  2017        PMID: 28622317      PMCID: PMC5733284          DOI: 10.1038/eye.2017.120

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  19 in total

1.  Epiphora: treatment by means of dacryocystoplasty with balloon dilation of the nasolacrimal drainage apparatus.

Authors:  P L Munk; D T Lin; D C Morris
Journal:  Radiology       Date:  1990-12       Impact factor: 11.105

2.  Assessing the Outcomes of Powered Endoscopic Dacryocystorhinostomy in Adults Using the Lacrimal Symptom (Lac-Q) Questionnaire.

Authors:  Mohammad Javed Ali; Sadiya Iram; Mohammad Hasnat Ali; Milind N Naik
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2017 Jan/Feb       Impact factor: 1.746

3.  Impact on quality of life of botulinum toxin treatments for essential blepharospasm.

Authors:  Kerr MacAndie; Ewan Kemp
Journal:  Orbit       Date:  2004-12

4.  Clinical research, comparison of the subjective visual function in patients with epiphora and patients with second-eye cataract.

Authors:  Namir Kafil-Hussain; Ramona Khooshebah
Journal:  Orbit       Date:  2005-03

5.  Patient-reported benefit from oculoplastic surgery.

Authors:  H B Smith; S B Jyothi; O A R Mahroo; P N Shams; M Sira; S Dey; T Adewoyin; V T F Cheung; C A Jones
Journal:  Eye (Lond)       Date:  2012-09-14       Impact factor: 3.775

6.  Development and validation of a symptom questionnaire for recording outcomes in adult lacrimal surgery.

Authors:  N Mistry; T J Rockley; T Reynolds; C Hopkins
Journal:  Rhinology       Date:  2011-12       Impact factor: 3.681

7.  The impact of endonasal dacryocystorhinostomy (DCR), on patient health status as assessed by the Glasgow benefit inventory.

Authors:  P M Spielmann; I Hathorn; F Ahsan; A J Cain; P S White
Journal:  Rhinology       Date:  2009-03       Impact factor: 3.681

8.  Patient satisfaction following endoscopic endonasal dacryocystorhinostomy: a quality of life study.

Authors:  G Jutley; R Karim; N Joharatnam; S Latif; T Lynch; J M Olver
Journal:  Eye (Lond)       Date:  2013-07-12       Impact factor: 3.775

9.  Management and outcomes of patients with epiphora referred to a specialist ophthalmic plastic unit.

Authors:  Daniel Sibley; Jonathan H Norris; Raman Malhotra
Journal:  Clin Exp Ophthalmol       Date:  2012-10-30       Impact factor: 4.207

10.  Outcomes of ptosis surgery assessed using a patient-reported outcome measure: an exploration of time effects.

Authors:  Omar A Mahroo; Pirro G Hysi; Sarju Dey; Elizabeth A Gavin; Christopher J Hammond; Carole A Jones
Journal:  Br J Ophthalmol       Date:  2013-12-16       Impact factor: 4.638

View more
  5 in total

1.  Comment on: Assessment of patient-reported outcome and quality of life improvement following surgery for epiphora.

Authors:  Valerie Juniat; Sarju Athwal; Adeela Malik; Mona Khandwala
Journal:  Eye (Lond)       Date:  2018-05-18       Impact factor: 3.775

2.  Risk of Ocular Adverse Events With Taxane-Based Chemotherapy.

Authors:  Mohit Sodhi; Sonia N Yeung; David Maberley; Frederick Mikelberg; Mahyar Etminan
Journal:  JAMA Ophthalmol       Date:  2022-09-01       Impact factor: 8.253

3.  A case report of optic neuropathy following dacryocystorhinostomy in a 57-year-old female patient with May-Hegglin anomaly.

Authors:  Seung Uk Lee; Hyoun Do Huh; Hyun Kyung Cho; Su Jin Kim
Journal:  BMC Ophthalmol       Date:  2020-04-19       Impact factor: 2.209

4.  Application of a symptoms score questionnaire after conjunctivodacryocystorhinostomy: outcomes.

Authors:  Andrea Iandelli; Andrea Luigi Camillo Carobbio; Renata Migliardi; Maurizio Catalani; Francesco Mazzola; Giampiero Parrinello; Giorgio Peretti; Frank Rikki Canevari
Journal:  Acta Otorhinolaryngol Ital       Date:  2021-06       Impact factor: 2.124

5.  Epiphora before and after upper eyelid functional blepharoplasty: A retrospective cohort study.

Authors:  Vannakorn Pruksakorn; Sunee Chansangpetch
Journal:  PLoS One       Date:  2021-08-12       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.